Related Experiment Video
Updated: Sep 9, 2025

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
Published on: May 2, 2025
Association Between Platelet Indices and Risk of Chronic Obstructive Pulmonary Disease: A Bidirectional Mendelian
Weifeng Liao1, Xiaoxi Lin1, Keyu Liu2
1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524003, People's Republic of China.
Introduction:
Platelet indices are associated with chronic obstructive pulmonary disease (COPD), their causal relationship remains unclear. This study aims to explore the causal relationship between four common platelet indices and COPD using Mendelian randomization (MR), including platelet count (PLT), plateletcrit (PCT), mean platelet volume (MPV), and platelet distribution width (PDW).
Methods:
We analyzed summary statistics from European-ancestry genome-wide association studies (GWAS) for platelet indices (UK Biobank, n=408,112) and COPD (FinnGen, n=433,208). MR analyses were performed using Inverse Variance Weighting (IVW), MR Egger (ME), Simple Mode (SM), Weighted Median (WMe), and Weighted Mode (WMo). Heterogeneity between SNPs was assessed using Cochran's Q test in combination with a random-effects IVW approach. MR-Egger intercept test and MR-PRESSO analysis demonstrate horizontal pleiotropy. Leave-one-out analysis to assess outlier-driven bias.
Results:
IVW analysis indicated that higher PLT was suggestively associated with increased COPD risk (OR = 1.054, 95% CI = 1.005-1.056, p = 0.029, FDR = 0.116). In the reverse direction, COPD was suggestively associated with increased PCT (OR = 1.025, 95% CI = 1.003-1.048, p = 0.024, FDR= 0.096). No significant associations were observed for MPV or PDW. Sensitivity analyses confirmed the robustness of results, with no signs of pleiotropy or reverse causality.
Conclusion:
Our bidirectional MR analysis found no definitive causal relationship between platelet indices and COPD, but observed suggestive associations between higher PLT/PCT and an increased risk of COPD. These findings warrant further investigation into the roles of platelet indices in COPD pathogenesis and their potential as biomarkers or therapeutic targets.
More Related Videos
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
08:17Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History